- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-994X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comprehensive pharmacogenomic characterization of gastric cancer ; volume:12 ; number:1 ; day:18 ; month:2 ; year:2020 ; pages:1-12 ; date:12.2020
Genome medicine ; 12, Heft 1 (18.2.2020), 1-12, 12.2020
- Urheber
-
Sa, Jason K.
Hong, Jung Yong
Lee, In-Kyoung
Kim, Ju-sun
Sim, Moon-Hee
Kim, Ha Jung
An, Ji Yeong
Sohn, Tae Sung
Lee, Joon Ho
Bae, Jae Moon
Kim, Sung
Kim, Kyoung-Mee
Kim, Seung Tae
Park, Se Hoon
Park, Joon Oh
Lim, Ho Yeong
Kang, Won Ki
Her, Nam-Gu
Lee, Yeri
Cho, Hee Jin
Shin, Yong Jae
Kim, Misuk
Koo, Harim
Kim, Mirinae
Seo, Yun Jee
Kim, Ja Yeon
Choi, Min-Gew
Nam, Do-Hyun
Lee, Jeeyun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13073-020-0717-8
- URN
-
urn:nbn:de:101:1-2020051503331969533127
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sa, Jason K.
- Hong, Jung Yong
- Lee, In-Kyoung
- Kim, Ju-sun
- Sim, Moon-Hee
- Kim, Ha Jung
- An, Ji Yeong
- Sohn, Tae Sung
- Lee, Joon Ho
- Bae, Jae Moon
- Kim, Sung
- Kim, Kyoung-Mee
- Kim, Seung Tae
- Park, Se Hoon
- Park, Joon Oh
- Lim, Ho Yeong
- Kang, Won Ki
- Her, Nam-Gu
- Lee, Yeri
- Cho, Hee Jin
- Shin, Yong Jae
- Kim, Misuk
- Koo, Harim
- Kim, Mirinae
- Seo, Yun Jee
- Kim, Ja Yeon
- Choi, Min-Gew
- Nam, Do-Hyun
- Lee, Jeeyun
- SpringerLink (Online service)
Ähnliche Objekte (12)
In silico comparative characterization of pharmacogenomic missense variants
A Landscape of Pharmacogenomic Interactions in Cancer
GDSCTools for Mining Pharmacogenomic Interactions in Cancer
Systematic identification of non-coding pharmacogenomic landscape in cancer
Progress and remaining challenges in comprehensive gastric cancer treatment
Pharmacogenomic Analyses of Next-Generation Sequencing Data from Cancer Patients
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes
Gastric Cancer: Molecular Characterization, Therapeutic Innovations, and Perspectives
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
In silico comparative characterization of pharmacogenomic missense variants
A Landscape of Pharmacogenomic Interactions in Cancer
GDSCTools for Mining Pharmacogenomic Interactions in Cancer
Systematic identification of non-coding pharmacogenomic landscape in cancer
Progress and remaining challenges in comprehensive gastric cancer treatment
Pharmacogenomic Analyses of Next-Generation Sequencing Data from Cancer Patients
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes
Gastric Cancer: Molecular Characterization, Therapeutic Innovations, and Perspectives
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
In silico comparative characterization of pharmacogenomic missense variants
A Landscape of Pharmacogenomic Interactions in Cancer
GDSCTools for Mining Pharmacogenomic Interactions in Cancer
Systematic identification of non-coding pharmacogenomic landscape in cancer
Progress and remaining challenges in comprehensive gastric cancer treatment
Pharmacogenomic Analyses of Next-Generation Sequencing Data from Cancer Patients
Discovering biomarkers of drug efficacy in cancer from pharmacogenomic data
Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes
Gastric Cancer: Molecular Characterization, Therapeutic Innovations, and Perspectives